Lot1, a zinc finger transcription factor acting as a tumor suppressor gene on tumoral cells, is highly expressed during brain development. In developing rat cerebellum, Lot1 expression is high in cerebellar granule cells (CGC), a neuronal population undergoing postnatal neurogenesis. The time course of Lot1 cerebellar expression closely matches the expression of pituitary adenylate cyclaseactivating polypeptide (PACAP) receptors coupled to adenylyl cyclase. The aim of this study was to ascertain whether Lot1 expression is regulated by cAMP-dependent pathways and to identify mechanisms of Lot1 activation in CGC cultures. Our results show that Lot1 expression in CGC is cAMP-dependent, as treatments with either forskolin or PACAP-38 induced an increase in its expression at both the mRNA and protein levels. This effect on Lot1 expression was mimicked by dibutyryl cAMP and suppressed by protein kinase A and MEK inhibitors. In parallel, we found that treatments with forskolin and PACAP-38 in precursor CGC inhibited bromodeoxyuridine incorporation by 25 and 35%, respectively, indicating a negative effect on neuronal precursor proliferation. Luciferase reporter analysis and mutagenesis of the Lot1 promoter region indicated a crucial role of the AP1-binding site (located at ؊268 bp) in cAMP-induced Lot1 transcription. In addition, cotransfection experiments indicated that the c-Fos/c-Jun heterodimer is responsible for cAMP-dependent Lot1 transcriptional activation. In conclusion, our data demonstrate that, in CGC, Lot1 is under the transcriptional control of cAMP through an AP1 site regulated by the c-Fos/c-Jun heterodimer and suggest that this gene may be an important element of the cAMP-mediated pathway that regulates neuronal proliferation through the protein kinase A-MEK signaling cascade.Lot1 was initially characterized as a growth suppressor gene based on its decrease in a rat ovarian carcinoma cell line and hence called Lot1 for "lost in transformation" (1, 2). Its mouse ortholog, which is highly homologous to the human and rat genes (LOT1 and Lot1, respectively), was independently identified by Spengler et al. (3,4) and designated as Zac1. The anti-proliferative properties of Zac1 were demonstrated by its ability to induce apoptosis and concomitantly to arrest the cell cycle in G 1 in osteosarcoma cell lines (3). In accordance with its anti-proliferative role, ablation of Zac1 gene expression increases cell proliferation (3, 5). Lot1 encodes a transcription factor with seven zinc fingers of the Cys 2 -His 2 type. The presence of a specific DNA-binding region for Lot1 makes it a transcriptional regulator, acting either as an activator or a repressor of nuclear receptor activity (6 -8). A splice variant of Lot/ Zac1 was independently identified in humans by Kas et al. (7) and named PLAGL1 based on its homology to PLAG1 protein, encoded by the PLAG1 gene localized on chromosome 8q12 (9). Northern blot analysis of different tissues revealed the highest expression of Zac1 mRNA in the pituitary gland, lower levels of ...